XML 119 R99.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue $ 12,398 $ 8,401
Cost of goods sold 2,258 1,193
Gross profit 10,140 7,208
Operating expenses:    
Research and development 21,358 14,224
Sales and marketing 12,738 8,263
General and administrative 12,483 8,753
Loss from operations (36,439) (24,032)
Interest earned on marketable securities held in Trust Account 180  
Interest expense (1) (1,761)
Loss on conversion of convertible notes   (3,416)
Loss on equity issuance (8,312)  
Change in fair value of tranche and warrant liabilities (2,186) (379)
Other income and expense, net (420) 746
Loss before income taxes (47,178) (28,842)
Income tax benefit (9) (3)
Net loss available to common stockholders (47,187) (28,845)
Deemed dividend related to Series B-2 preferred stock down round provision (2,829)  
Net loss attributable to common stockholders $ (50,016) $ (28,845)
Basic net (loss) income per share $ (161.55) $ (131.65)
Diluted net (loss) income per share $ (161.55) $ (131.65)
Weighted average shares outstanding, basic 309,609 219,100
Weighted average shares outstanding, diluted 309,609 219,100